Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark T Osterman

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Inflammatory Bowel Diseases|January 15, 2010
To TNF or not to TNF: that is the questionMark T Osterman
Inflammatory Bowel Diseases|March 15, 2006
Risky business? Crohn's disease-related mortalityMark T Osterman
Gastroenterology|June 29, 2014
Reply: To PMID 24361468Mark T Osterman,
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 25, 2014
Reply: To PMID 23811254Mark T Osterman
Journal of Clinical Gastroenterology|January 24, 2013
Mucosal healing in inflammatory bowel diseaseMark T Osterman
Inflammatory Bowel Diseases|February 10, 2009
Big risk, small risk: small bowel cancer in Crohn's diseaseMark T Osterman
Inflammatory Bowel Diseases|February 19, 2016
How to Diagnose and Treat IBD Mimics in the Refractory IBD Patient Who Does Not Have IBDKaren A Chachu, Mark T Osterman
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 22, 2015
Natalizumab for Crohn's Disease: Down but Not OutFrank I Scott, Mark T Osterman
Methods and Findings in Experimental and Clinical Pharmacology|April 10, 2009
Reformulation of an aminosalicylate: an example of the importance of pill burden on medical compliance ratesMark T Osterman, Gary R Lichtenstein
Current Treatment Options in Gastroenterology|June 6, 2007
Current and Future Anti-TNF Therapy for Inflammatory Bowel DiseaseMark T Osterman, Gary R Lichtenstein
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Inflammatory Bowel Diseases|January 15, 2010
To TNF or not to TNF: that is the questionMark T Osterman
Inflammatory Bowel Diseases|March 15, 2006
Risky business? Crohn's disease-related mortalityMark T Osterman
Gastroenterology|June 29, 2014
Reply: To PMID 24361468Mark T Osterman,
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 25, 2014
Reply: To PMID 23811254Mark T Osterman
Journal of Clinical Gastroenterology|January 24, 2013
Mucosal healing in inflammatory bowel diseaseMark T Osterman
Inflammatory Bowel Diseases|February 10, 2009
Big risk, small risk: small bowel cancer in Crohn's diseaseMark T Osterman
Inflammatory Bowel Diseases|February 19, 2016
How to Diagnose and Treat IBD Mimics in the Refractory IBD Patient Who Does Not Have IBDKaren A Chachu, Mark T Osterman
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 22, 2015
Natalizumab for Crohn's Disease: Down but Not OutFrank I Scott, Mark T Osterman
Methods and Findings in Experimental and Clinical Pharmacology|April 10, 2009
Reformulation of an aminosalicylate: an example of the importance of pill burden on medical compliance ratesMark T Osterman, Gary R Lichtenstein
Current Treatment Options in Gastroenterology|June 6, 2007
Current and Future Anti-TNF Therapy for Inflammatory Bowel DiseaseMark T Osterman, Gary R Lichtenstein
Pageof 7